5:08 PM
 | 
Aug 29, 2007
 |  BC Extra  |  Clinical News

Bronchitol meets bronchiectasis endpoints

Pharmaxis (ASX:PXS; PXSL) said Bronchitol met the primary endpoints of significantly improved quality of life and mucus clearance vs....

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >